Artal Group’s Recursion Pharmaceuticals RXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-960,204
| Closed | -$7.4M | – | 137 |
|
|
2022
Q4 | $7.4M | Buy |
960,204
+510,204
| +113% | +$3.93M | 0.41% | 47 |
|
|
2022
Q3 | $4.79M | Hold |
450,000
| – | – | 0.2% | 57 |
|
|
2022
Q2 | $3.66M | Hold |
450,000
| – | – | 0.2% | 69 |
|
|
2022
Q1 | $3.22M | Buy |
450,000
+250,000
| +125% | +$1.79M | 0.13% | 97 |
|
|
2021
Q4 | $3.43M | Hold |
200,000
| – | – | 0.09% | 112 |
|
|
2021
Q3 | $4.6M | Hold |
200,000
| – | – | 0.1% | 111 |
|
|
2021
Q2 | $7.3M | Buy |
+200,000
| New | +$7.3M | 0.15% | 101 |
|